About: Effectiveness of Antibiotic Use Management in Tianjin (2011

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effectiveness of Antibiotic Use Management in Tianjin (2011–2013): A Quasi-Experimental Study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Effectiveness of Antibiotic Use Management in Tianjin (2011–2013): A Quasi-Experimental Study
Creator	Liu, Wei Du, Yue Huang, Guo-Wei Song, Shi-Duo Wang, He-Sheng Zhang, Hai-Hong Zhao, Wen Abe,
source	Medline; PMC
abstract	BACKGROUND: In this study we investigated changes in the status of antibiotic use in Tianjin since the implementation of the Antibiotic Stewardship Program (ASP) (2011–2013), as well as existing problems, strategies, and outcomes to promote rational clinical antibiotic use. MATERIAL/METHODS: A quasi-experimental study was performed to investigate situations of antibiotic use in secondary and tertiary general hospitals in Tianjin from April 2011 to 2013. Five major indicators were analyzed: percentage of antibiotic use in inpatient cases (%), antibacterial use density (AUD), proportion of prophylactic antibiotic application for type I surgical incision, compliance rate of medication administration 0.5–2.0 h before such procedures, and antibiotic prophylaxis for ≤24 h in patients receiving these surgeries. RESULTS: There was a decrease in the percentage of antibiotic use across general hospitals (60.38% to 46.88%), in AUD (51.60% to 35.37%), and in the proportion of prophylactic antibiotic applications for type I incisions (86.67% to 25.08%). For patients undergoing these procedures, there was an increased compliance rate of medication administration of 0.5–2.0 h prior to surgery (86.38% to 100%), and of antibiotic prophylactic use for ≤24 h (40.30% to 96.37%). CONCLUSIONS: Implementation of the ASP campaign has reduced irrational antibiotic use, promoted rational antibiotic use, and delayed antibiotic resistance.
has issue date	2017-02-09(xsd:dateTime)
bibo:doi	10.12659/msm.899848
bibo:pmid	28179620
has license	no-cc
sha1sum (hex)	5a7af4bc5cc14fbcd0bcc8d26515478c65a24406
schema:url	https://doi.org/10.12659/msm.899848
resource representing a document's title	Effectiveness of Antibiotic Use Management in Tianjin (2011–2013): A Quasi-Experimental Study
has PubMed Central identifier	PMC5317282
has PubMed identifier	28179620
schema:publication	Med Sci Monit
resource representing a document's body	covid:5a7af4bc5cc14fbcd0bcc8d26515478c65a24406#body_text
is schema:about of	named entity '2011' named entity 'Study' named entity 'TIANJIN' named entity 'QUASI-EXPERIMENTAL STUDY' named entity 'EFFECTIVENESS' named entity 'MANAGEMENT' named entity 'ANTIBIOTIC USE' named entity 'Experimental Study' named entity 'antibiotic' named entity 'Antibiotic resistance' named entity 'infectious diseases' named entity 'China' named entity 'information technology' named entity 'antibiotic' named entity 'WHO' named entity 'general hospitals' named entity 'antibiotic' named entity 'Antibiotic' named entity 'Middle East' named entity 'Acinetobacter baumannii' named entity 'Mexico' named entity 'pharmacokinetic' named entity 'antibiotic resistance' named entity 'clinical pharmacists' named entity 'antibiotic' named entity 'antibiotic' named entity 'vancomycin' named entity 'first-generation cephalosporin' named entity 'antibiotic' named entity 'antibiotic' named entity 'bacterial resistance' named entity 'epidemiology' named entity 'Pseudomonas aeruginosa' named entity 'Quality Control' named entity 'antibiotic' named entity 'fluoroquinolone' named entity 'antibiotic' named entity 'anti-inflammatory' named entity 'hypothermia' named entity 'antibiotic' named entity 'antibiotic resistance' named entity 'antibiotic' named entity 'antibiotics' named entity 'antibiotic prophylaxis' named entity 'antibiotic' named entity 'information technology' named entity 'ceftriaxone' named entity 'Tianjin' named entity 'DDDs' named entity 'antibiotic' named entity 'antibiotic prophylaxis' named entity 'prophylactic' named entity 'antibiotics' named entity 'DDDs' named entity 'antibiotic' named entity 'antibiotic' named entity 'infectious diseases' named entity '2.0' named entity 'meropenem' named entity 'China' named entity 'infection' named entity 'disease control' named entity 'prophylactic' named entity 'antibiotic' named entity 'antibiotic' named entity 'p-value' named entity 'antibiotics' named entity 'World Health Organization' named entity 'AUD' named entity 'acquired immune deficiency syndrome' named entity 'antibiotic' named entity 'prevention and control' named entity 'directly controlled municipalities' named entity 'DDDs'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software